Enhanced Systems and Methods for Delivering Microdoses of Medication

Improved wearable insulin pumps and methods for delivering microdoses of medication, incorporating advanced sensors, machine learning algorithms, and personalized dosing to enhance glucose control and prevent hypoglycemic events.

The original patent, 'Systems and methods for delivering microdoses of medication,' provided a foundational wearable insulin pump system for delivering small doses of insulin. However, limitations existed in terms of glucose control, physical activity detection, and personalized dosing. The new inventive concept addresses these limitations by integrating advanced sensors, machine learning algorithms, and personalized dosing to improve glucose control and prevent hypoglycemic events.

The new inventive concept comprises four primary components: 1) an integrated sensor to monitor insulin levels and adjust dosing accordingly, 2) machine learning algorithms to analyze user data and adjust the basal rate of insulin delivery based on patterns and trends, 3) a built-in accelerometer to detect and respond to physical activity, and 4) personalized insulin dosing based on a user's genetic profile. These components work in concert to provide real-time glucose monitoring, adaptive insulin delivery, and personalized treatment plans. The wearable insulin pump system is further enhanced by a cloud-based platform for remote monitoring, tracking, and analysis of user data, providing real-time alerts and recommendations for improved glucose management.

The new inventive concept's integration of advanced sensors, machine learning algorithms, and personalized dosing represents a significant departure from the original patent. The use of machine learning to analyze user data and adjust insulin delivery, as well as the incorporation of genetic profiling for personalized dosing, are novel and non-obvious improvements that enhance glucose control and prevent hypoglycemic events.

Alternative embodiments of the inventive concept could include the use of different types of sensors, such as continuous glucose monitors or implantable sensors, or the integration of additional health metrics, such as heart rate or blood pressure. Variations could also include the use of different machine learning algorithms or the incorporation of additional data sources, such as electronic health records or social media data.

The enhanced systems and methods for delivering microdoses of medication have significant commercial potential in the diabetes management market, with potential applications in wearable insulin pumps, continuous glucose monitoring systems, and personalized medicine. The target market includes individuals with Type I and Type II diabetes, as well as healthcare providers and payers seeking to improve glucose control and reduce healthcare costs.